Rxsight Inc

$14.72
(as of Apr 30, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Rxsight Inc

Stock Price
$14.72
Ticker Symbol
RXST
Exchange
NASDAQ

Industry Information for Rxsight Inc

Sector
Healthcare
Industry
Medical Devices

Company Description for Rxsight Inc

Country
USA
Full Time Employees
498

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Fundamentals for Rxsight Inc

Market Capitalization
$591,430,144
EBITDA
$-33,283,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
116.28
Earnings per Share
$-0.71
Earnings per Share Estimate Next Year
Profit Margin
-19.62%
Shares Outstanding
40,620,200
Percent Owned by Insiders
5.06%
Percent Owned by Institutions
96.25%
52-Week High
52-Week Low

Technical Indicators for Rxsight Inc

50-Day Moving Average
200-Day Moving Average
RSI
31.55
1.17

Analyst Ratings for Rxsight Inc

Strong Buy
5
Buy
3
Hold
2
Sell
0
Strong Sell
0

News About Rxsight Inc

Apr 30, 2025, 4:05 PM EST
ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference in Las Vegas. See more.
Apr 30, 2025, 10:01 AM EST
Wall Street expects a year-over-year increase in earnings on higher revenues when RxSight, Inc. See more.
Apr 4, 2025, 11:46 AM EST
Investing.com -- JP Morgan downgraded RxSight to Underweight, citing market, economic, and competitive headwinds that have led to a weaker-than-expected first-quarter performance and a downward revision to 2025 guidance. See more.
Apr 4, 2025, 9:40 AM EST
The most talked about and market moving research calls around Wall Street are now in one place. See more.